WS #12598

The US-Iran conflict continues to escalate (ESCALATING), with the 11th consecutive night of US airstrikes on Iran, active air defense over Tehran, and Iran retaliating with strikes on US assets in Jordan, Bahrain, and Kuwait, including attacks on oil tankers in the Strait of Hormuz. The war cost has reached $37.5 billion, and the Pentagon is seeking $88 billion in supplemental funding. However, a key counter-signal emerged: Trump approved a landmark 30-year nuclear deal with Saudi Arabia, potentially allowing uranium enrichment, which could reshape Middle East alliances and energy markets. Separately, Trump announced a phased tariff on generic drugs starting in 2028, escalating trade tensions. On the positive side, Wall Street closed higher (S&P 500 +0.9%, Nasdaq +1.3%) led by AI/semiconductor stocks (Micron +12.2%, Nvidia +2%), and Bitcoin reclaimed $66K. The dominant theme remains the US-Iran conflict, but the Saudi nuclear deal and generic drug tariffs are new high-significance developments.